论文信息 - Phase IB/II Study of Second-Line Therapy with Panitumumab, Irinotecan, and Everolimus (PIE) in KRAS Wild-Type Metastatic Colorectal Cancer - 字舞流文

Phase IB/II Study of Second-Line Therapy with Panitumumab, Irinotecan, and Everolimus (PIE) in KRAS Wild-Type Metastatic Colorectal Cancer

C. Karapetis | T. Price | N. Tebbutt | J. Hardingham | L. Pirc | A. Townsend | R. Joshi | N. Singhal | S. Yeend | P. Cooper